首页>
外国专利>
USING ALLOPURINOL FOR TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA SYNDROME
USING ALLOPURINOL FOR TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA SYNDROME
展开▼
机译:使用异普尿酚治疗Palmar-Plantar红细胞感觉异常综合征
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to the pharmaceutical industry and represents a therapeutic agent used for treating or preventing palmar-plantar erythrodysesthesia syndrome (PPES) induced by a multifunction kinase inhibitor (MKI) therapy and containing a therapeutically effective amount of allopurinol or its pharmaceutically acceptable salt.;EFFECT: invention provides extending the range of products for treating or preventing palmar-plantar erythrodysesthesia syndrome (PPES) induced by the multifunction kinase inhibitor (MKI) therapy.;21 cl, 5 ex
展开▼
机译:领域:药物,药物。发明领域:涉及药物工业,并且代表一种用于治疗或预防由多功能激酶抑制剂(MKI)疗法引起的掌-红斑感觉综合症(PPES)的治疗剂,并含有治疗有效量的别嘌呤醇或其药学上可接受的盐;效果:本发明提供了扩大的产品范围,用于治疗或预防由多功能激酶抑制剂(MKI)治疗引起的掌-红斑感觉异常综合征(PPES)。21cl,5 ex
展开▼